Log in
Enquire now
‌

US Patent 9688744 High affinity human antibodies to human cytomegalovirus (CMV) GB protein

Patent 9688744 was granted and assigned to Trellis Bioscience on June, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Trellis Bioscience
Trellis Bioscience
0
Current Assignee
Trellis Bioscience
Trellis Bioscience
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96887440
Patent Inventor Names
Ying-Ping Jiang0
Orit Foord0
Stote Ellsworth0
William Usinger0
Bo Chen0
Fen Zhang0
Gizette Sperinde0
Krista Maureen McCutcheon0
...
Date of Patent
June 27, 2017
0
Patent Application Number
146974590
Date Filed
April 27, 2015
0
Patent Primary Examiner
‌
Janet L. Andres
0
Patent abstract

Recombinant monoclonal antibodies to human cytomegalovirus (CMV) gB protein are described. The affinities of these antibodies are higher than the best previously reported antibodies. Since high affinity is critical to prevention of virus transfer across the placenta, the invention antibodies are useful as therapeutic and prophylactic agents to prevent or ameliorate effects on the fetus of CMV infection during pregnancy.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9688744 High affinity human antibodies to human cytomegalovirus (CMV) GB protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.